z-logo
Premium
Synthesis, Characterization, and Enhanced Cancer‐Imaging Application of Trans‐activator of Transcription Peptide‐conjugated Ultrasmall Gadolinium Oxide Nanoparticles
Author(s) -
Ahmad Mohammad Yaseen,
Cha Hyunsil,
Oh InTaek,
Tegafaw Tirusew,
Miao Xu,
Ho Son Long,
Marasini Shanti,
Ghazanfari Adibehalsadat,
Yue Huan,
Chae Kwon Seok,
Chang Yongmin,
Lee Gang Ho
Publication year - 2018
Publication title -
bulletin of the korean chemical society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.237
H-Index - 59
ISSN - 1229-5949
DOI - 10.1002/bkcs.11404
Subject(s) - in vivo , gadolinium , conjugated system , magnetic resonance imaging , chemistry , in vitro , peptide , cancer cell , materials science , nuclear magnetic resonance , nuclear chemistry , cancer , medicine , biochemistry , organic chemistry , physics , microbiology and biotechnology , radiology , biology , polymer
We prepared gadolinium oxide (Gd 2 O 3 ) nanoparticles (GNPs) coated with a trans‐activator of transcription (TAT) peptide with cell‐penetrating ability ( i.e ., TAT‐GNPs) through one‐pot process. We characterized the particle diameter, surface‐coating structure, water proton relaxivities, and in vitro cellular toxicities of the TAT‐GNPs. We measured in vivo T 1 magnetic resonance images (MRI) in a model nude mouse with liver cancer prior and posterior to intravenous administration. The average particle diameter of the GNPs was 1.5 nm. The sample solution exhibited a longitudinal water proton relaxivity (r 1 ) of 18.2/s/mM (r 2 /r 1 = 1.6, r 2 = transverse water proton relaxivity), which is four to five times higher than those of commercial Gd‐chelates. The in vivo T 1 MRI exhibited positively (or T 1 ) enhanced contrasts in the mouse liver cancer after intravenous administration, demonstrating that the TAT‐GNPs acted as an enhanced cancer‐imaging agent similar to the cancer‐targeting agent in T 1 MRI.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom